AACE Annual Meeting
Pituitary and Neuroendocrine
Adriana G. Ioachimescu, MD, PhD, FACE
Professor of Medicine (Endocrinology) and Neurosurgery
Emory University
Atlanta, Georgia, United States
Disclosure: Chiasma (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing), Research Grant (Status: Ongoing); Chiasma, currently Amryt (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing), Multicentric phase III trial (Status: Ongoing), Research Grant (Status: Ongoing); HRA Pharma (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing); Ipsen (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing); Novartis (Self) : Multicentric phase III trial (Status: Terminated --- 2020), Research Grant (Status: Terminated --- 2020); Pfizer (Self) : Consulting Fees (e.g., advisory boards) (Status: Terminated --- 2019), Research Grant (Status: Terminated --- 2019); Recordati (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing), Research Grant (Status: Ongoing); Strongbridge, currently Xeris (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing), Multicentric phase III trial (Status: Ongoing), Research Grant (Status: Ongoing); Tiburio (Self) : Consulting Fees (e.g., advisory boards) (Status: Terminated --- 2020)
Diane Donegan, MD
Assistant Professor of Clinical Medicine
Indiana University
Indianapolis, Indiana, United States
Disclosure: Corcept (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing), Contracted Research (Status: Ongoing); Recordati (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing)